> Products > Active Pharmaceutical Ingredient (API) > Apremilast > (+)-N-［2-［1(S)-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl］-1,3-dioxo-2,3-dihydro-1H-isoindol-4 -yl］acetamide

New Products

(+)-N-［2-［1(S)-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl］-1,3-dioxo-2,3-dihydro-1H-isoindol-4 -yl］acetamide

Seres operis nomen: Aprester
Sinensis alias: (S) -2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl] -4-acetylaminoisoindoline-1,3 -diketone
Anglicus operis nomen: Apremilast
Cas#608141-41-9
Formulae hypotheticae: C22H24N2O7S
Pondus hypotheticum: 460.5
(+)-N-［2-［1(S)-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl］-1,3-dioxo-2,3-dihydro-1H-isoindol-4 -yl］acetamide est medicamentum psoriaticum arthritis, psorasis et arthritis psoriatica medicamentum.

Mitte Inquisitionem

depictio producti

Formulae

Seres operis nomen: Aprester

Sinensis alias: (S) -2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl] -4-acetylaminoisoindoline-1,3 -diketone

Anglicus operis nomen: Apremilast

Cas#608141-41-9

Formulaee hypotheticae: C22H24N2O7S

Pondus hypotheticum: 460.5

Species et possessiones: Off-alba pulveris

(+)-N-［2-［1(S)-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl］-1,3-dioxo-2,3-dihydro-1H-isoindol-4 -yl］acetamide est medicamentum psoriaticum arthritis, psorasis et arthritis psoriatica medicamentum.

Syntaxis: Apremilast oralis est, phosphodiesterasus selectivus 4 (PDE4) inhibitor evoluta a comitatu Americano Celgene, nomine artis Otezla. Hoc medicamentum primum et unicum medicamentum FDA probatum est pro tabula argenti. PDE4 inhibitor pro curatione psoriasis, pro curatione aegrorum adultorum moderatis ad psoriasin gravibus (Plaque Psoriasis) aptae ad therapiam et systemicam therapiam.

Hot Tags: (+)-N-［2-［1(S)-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl］-1,3-dioxo-2,3-dihydro-1H-isoindol-4 -yl］acetamide, China, Manufacturer, Supplier, Factory, Quality